Bile acid metabolism and signaling, the microbiota, and metabolic disease

J Cai, B Rimal, C Jiang, JYL Chiang… - Pharmacology & …, 2022 - Elsevier
The diversity, composition, and function of the bacterial community inhabiting the human
gastrointestinal tract contributes to host health through its role in producing energy or …

Molecular physiology of bile acid signaling in health, disease, and aging

A Perino, H Demagny… - Physiological …, 2021 - journals.physiology.org
Over the past two decades, bile acids (BAs) have become established as important
signaling molecules that enable fine-tuned inter-tissue communication from the liver, their …

Gut microbiota in hypertension and atherosclerosis: a review

BJH Verhaar, A Prodan, M Nieuwdorp, M Muller - Nutrients, 2020 - mdpi.com
Gut microbiota and its metabolites such as short chain fatty acids (SCFA),
lipopolysaccharides (LPS), and trimethylamine-N-oxide (TMAO) impact cardiovascular …

Bile acids and their receptors in metabolic disorders

S Fiorucci, E Distrutti, A Carino, A Zampella… - Progress in Lipid …, 2021 - Elsevier
Bile acids are a large family of atypical steroids which exert their functions by binding to a
family of ubiquitous cell membrane and nuclear receptors. There are two main bile acid …

[HTML][HTML] New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond

U Beuers, M Trauner, P Jansen, R Poupon - Journal of hepatology, 2015 - Elsevier
Cholestasis is an impairment of bile formation/flow at the level of the hepatocyte and/or
cholangiocyte. The first, and for the moment, most established medical treatment is the …

[HTML][HTML] Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid

GM Hirschfield, A Mason, V Luketic, K Lindor… - Gastroenterology, 2015 - Elsevier
Background & Aims We evaluated the efficacy and safety of obeticholic acid (OCA, α-
ethylchenodeoxycholic acid) in a randomized controlled trial of patients with primary biliary …

[HTML][HTML] Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases

B Guan, J Tong, H Hao, Z Yang, K Chen, H Xu… - … Pharmaceutica Sinica B, 2022 - Elsevier
Cardiometabolic disease (CMD), characterized with metabolic disorder triggered
cardiovascular events, is a leading cause of death and disability. Metabolic disorders trigger …

Bile acid receptors as targets for drug development

FG Schaap, M Trauner, PLM Jansen - Nature reviews Gastroenterology …, 2014 - nature.com
The intracellular nuclear receptor farnesoid X receptor and the transmembrane G protein-
coupled receptor TGR5 respond to bile acids by activating transcriptional networks and/or …

[HTML][HTML] FXR in liver physiology: Multiple faces to regulate liver metabolism

K Panzitt, M Wagner - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2021 - Elsevier
The liver is the central metabolic hub which coordinates nutritional inputs and metabolic
outputs. Food intake releases bile acids which can be sensed by the bile acid receptor FXR …

Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives

H Hu, A Lin, M Kong, X Yao, M Yin, H Xia, J Ma… - Journal of …, 2020 - Springer
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of dysregulated lipid
and glucose metabolism, which is often associated with obesity, dyslipidemia and insulin …